A citation-based method for searching scientific literature

S M Grunberg, M H Weiss. J Neurooncol 1990
Times Cited: 42







List of co-cited articles
316 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
S M Grunberg, M H Weiss, I M Spitz, J Ahmadi, A Sadun, C A Russell, L Lucci, L L Stevenson. J Neurosurg 1991
275
66

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.
S E Kaba, F DeMonte, J M Bruner, A P Kyritsis, K A Jaeckle, V Levin, W K Yung. Neurosurgery 1997
95
40

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Warren P Mason, Fred Gentili, David R Macdonald, Subramanian Hariharan, Charlene R Cruz, Lauren E Abrey. J Neurosurg 2002
104
40

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study.
J W Goodwin, J Crowley, H J Eyre, B Stafford, K A Jaeckle, J J Townsend. J Neurooncol 1993
98
38

Temozolomide for treatment-resistant recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. Neurology 2004
101
38

Salvage chemotherapy with CPT-11 for recurrent meningioma.
Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen. J Neurooncol 2006
64
38

Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
J Jääskeläinen, E Laasonen, J Kärkkäinen, M Haltia, H Troupp. Acta Neurochir (Wien) 1986
51
35


Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Marc C Chamberlain, Michael J Glantz, Camilo E Fadul. Neurology 2007
122
30

Meningioma: analysis of recurrence and progression following neurosurgical resection.
R O Mirimanoff, D E Dosoretz, R M Linggood, R G Ojemann, R L Martuza. J Neurosurg 1985
762
28

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, Andrew D Norden, Timothy F Cloughesy, Lauren E Abrey, Howard A Fine, Susan M Chang, H Ian Robins, Karen Fink,[...]. Neuro Oncol 2009
91
28


Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Steven M Grunberg, Martin H Weiss, Christy A Russell, Irving M Spitz, Jamshid Ahmadi, Alfredo Sadun, Regine Sitruk-Ware. Cancer Invest 2006
108
26

Hormonal manipulation of meningiomas in vitro.
J J Olson, D W Beck, J Schlechte, P M Loh. J Neurosurg 1986
107
23


Mifepristone (RU 486) treatment of meningiomas.
S W Lamberts, H L Tanghe, C J Avezaat, R Braakman, R Wijngaarde, J W Koper, H de Jong. J Neurol Neurosurg Psychiatry 1992
111
23

Hydroxyurea chemotherapy for unresectable or residual meningioma.
H B Newton, M A Slivka, C Stevens. J Neurooncol 2000
76
23

Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
J J Olson, D W Beck, J A Schlechte, P M Loh. J Neurosurg 1987
92
23

Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay.
S M Grunberg, A M Daniels, H Muensch, J R Daniels, L Bernstein, V Kortes, M H Weiss. J Neurosurg 1987
48
23

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, Kathleen R Lamborn, Andrew B Lassman, Susan M Chang, W K Alfred Yung, Mark R Gilbert, Howard A Fine, Minesh Mehta,[...]. J Neurooncol 2010
110
23


Chemotherapy for meningiomas.
A P Kyritsis. J Neurooncol 1996
61
21

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
U M Schrell, M G Rittig, M Anders, U H Koch, R Marschalek, F Kiesewetter, R Fahlbusch. J Neurosurg 1997
132
21

Antiestrogenic therapy of meningiomas--a pilot study.
T M Markwalder, R W Seiler, D T Zava. Surg Neurol 1985
46
21

Treatment of high risk or recurrent meningiomas with hydroxyurea.
Mark A Rosenthal, David L Ashley, Lawrence Cher. J Clin Neurosci 2002
50
21

Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Y Matsuda, K Kawamoto, K Kiya, K Kurisu, K Sugiyama, T Uozumi. J Neurosurg 1994
65
19






Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.
T M Markwalder, D T Zava, A Goldhirsch, R V Markwalder. Surg Neurol 1983
109
16

Progesterone and estrogen receptors in meningiomas: prognostic considerations.
D W Hsu, J T Efird, E T Hedley-Whyte. J Neurosurg 1997
238
16

The relapsing course of certain meningiomas in relation to pregnancy and menstruation.
E R BICKERSTAFF, J M SMALL, I A GUEST. J Neurol Neurosurg Psychiatry 1958
248
16

Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Barbara M Hahn, Ulrich M H Schrell, Rolf Sauer, Rudolf Fahlbusch, Oliver Ganslandt, Gerhard G Grabenbauer. J Neurooncol 2005
41
17

Non-resectable slow-growing meningiomas treated by hydroxyurea.
David Loven, Ruth Hardoff, Zvi Bar Sever, Adam P Steinmetz, Michael Gornish, Zvi H Rappaport, Eyal Fenig, Zvi Ram, Aaron Sulkes. J Neurooncol 2004
60
16


Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
111
16


Response criteria for phase II studies of supratentorial malignant glioma.
D R Macdonald, T L Cascino, S C Schold, J G Cairncross. J Clin Oncol 1990
14


Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.
C Muhr, O Gudjonsson, A Lilja, M Hartman, Z J Zhang, B Långström. Clin Cancer Res 2001
43
14

Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
D H Gutmann, J Donahoe, A Perry, N Lemke, K Gorse, K Kittiniyom, S A Rempel, J A Gutierrez, I F Newsham. Hum Mol Genet 2000
148
14


Estrogen-receptor protein in intracranial meningiomas.
M S Donnell, G A Meyer, W L Donegan. J Neurosurg 1979
202
14


Exogenous hormone use and meningioma risk: what do we tell our patients?
Elizabeth B Claus, Peter M Black, Melissa L Bondy, Lisa Calvocoressi, Joellen M Schildkraut, Joseph L Wiemels, Margaret Wrensch. Cancer 2007
74
14

Aberrant signaling pathways in meningiomas.
Brian T Ragel, Randy L Jensen. J Neurooncol 2010
46
14

Medical therapies for meningiomas.
Patrick Y Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim, Andrew D Norden. J Neurooncol 2010
103
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.